002950Allmed MedicalSZSE

Allmed Medical Products Co., Ltd.

奥美医疗

002950

Shenzhen Stock Exchange

BoardMain Board of Shenzhen Stock Exchange
IndustryPharmaceutical Manufacturing
ListedMarch 11, 2019
Websitehttps://www.allmed.cn/
IR Emailir@allmed.cn
Phone(+86)755-88299832
Address19F, Block A, Taurus Plaza, No.8 Taoyuan Road, Nanshan District, Shenzhen, Guangdong

Company Profile

(I) Advanced manufacturing advantages 1.Comprehensive Industrial Chain and Advanced Equipment Our company stands as one of the select few in the industry, boasting a comprehensive industrial chain and advanced automation capabilities. Over two decades of development, we have amassed substantial industry and production expertise. Through relentless innovation and strategic integration, we have established a systematic production line that aligns with industry-specific characteristics and rivals international standards, encompassing the entire spectrum of production from raw materials and semi-finished goods to deep processing, packaging, sterilization, and testing. We have adopted state-of-the-art production equipment from abroad and concurrently intensified our efforts in the independent development of specialized machinery, securing a portfolio of patents. Our ongoing equipment and process upgrades have bolstered the automation and intelligence across each link of our industrial chain, enhancing the synergy of our integrated production strategy. This comprehensive approach allows us to sustain our competitive edge by ensuring product quality, minimizing production costs, and elevating the level of automation. 2.Scale Production Advantage Our company's dressings are primarily targeted at the European and American markets, where the dressings industry is highly competitive and concentrated. To maintain a competitive price-performance ratio and secure a market foothold, large-scale production capacity is imperative. The diverse needs of downstream customers in terms of product quantity, variety, models, and appearance necessitate a certain level of production scale to ensure timely supply and meet the demands for diversity. Scale production is a pivotal foundation for securing a competitive advantage in the market. After years of development, our company has cultivated a pronounced scale production advantage. As a leading producer and exporter in China's medical dressings industry, we operate multiple production bases equipped with cutting-edge equipment, achieving a high degree of large-scale production. This significant scale advantage has substantially increased our production efficiency and effectively reduced costs. It also ensures the consistency and stability of product quality, meets the timeliness of batch deliveries, and addresses the diversity of procurement needs, thereby enhancing our overall competitiveness and market share. 3.Automation, Informationization, and Intelligent Manufacturing Advantages Our company is among the select few globally with capabilities in high automation, informationization, and intelligent manufacturing. We have evolved from leveraging production management advantages to scaling up production, and now to the forefront of automation, intelligentization, and informationization in manufacturing. By elevating the integration of technology, we have raised the benchmark for maintaining our manufacturing advantages to a new level of technological convergence. (III) Technological Innovation Advantage The company's business strategy is based on the principle of technological innovation, which it regards as the primary driver of growth. It makes a sustained commitment to research and development (R&D), continuously optimising processes, innovating production equipment and technology, and attracting and nurturing talented individuals with innovative skills. These efforts have resulted in the establishment of a comprehensive and effective R&D system, which has reinforced the company's competitive advantage within its industry. As a high-tech enterprise with a focus on medical dressings, the company has obtained the requisite invention patent authorization, accumulated a substantial corpus of technical achievements, and maintained its leading position in the medical dressing industry. In addition to sustaining investment in product innovation and enhancement, equipment modernization, and renovation, the company has augmented its investment in automation, informationization, and intelligent management. This has resulted in the acquisition of several software copyrights, including the "Allmed Medical WMS Management System," the Allmed Barcode Management System," the Allmed & Mather WMS Management System," the Allmed Barcode Management System," the Allmed ETO Sterilization Process Visualization Management Software," and numerous others. (IV) Market Resource Advantage The company adheres to the core values of "integrity, focus, professionalism," and continues to provide customers with high-quality products and services. Medical dressing products are mainly used for export and are sold to nearly 40 countries or regions on six continents. The majority of sales are to the United States, Canada, Germany, Japan, and other countries and regions. Overseas customers are primarily internationally renowned brands, and the company has established long-term and stable cooperative relationships, forming an outstanding customer resource advantage. The company's overseas customers are primarily international brands with which it has established long-term and stable cooperative relationships, thereby acquiring a significant competitive advantage in terms of customer resources. In recent years, the company has witnessed a continued increase in its market share in certain key markets. The company has been engaged in the medical and healthcare business for an extended period, addressing customer requirements pertaining to product quality, production capacity assurance, delivery time, customer service, and other aspects. It has established a robust customer service infrastructure and cultivated stable customer relationships through the provision of high-quality pre- and post-sales support. Presently, the company's global customer base encompasses Medline, Dukal, Hartmann, Lohmann & Rauscher, Medicom, Johnson & Johnson, and other globally renowned enterprises. Through long-term strategic collaboration with these esteemed partners, the company has witnessed a symbiotic growth trajectory, with its products gaining recognition and customer loyalty. This has enabled the company to achieve sustainable development and maintain its core competitiveness.

Full description

Allmed Medical Products Company Limited (hereinafter referred to as ‘the Company’) was founded in Hong Kong in 1997 and listed on the Shenzhen Stock Exchange in March 2019 (002950.SZ), which is the first A-share listed enterprise in Zhijiang. The Company is a leading global provider of medical dressings and infection protection solutions. The company's products are sold to nearly 70 countries or regions in six continents, and have been steadily topping the export list of China's medical dressing industry since 2008, according to the statistics of the CHINA CHAMBER OF COMMERCE FOR IMPORT & EXPORT OF MEDICINES & HEALTH PRODUCTS. The company was listed on the Shenzhen Stock Exchange at the end of March 2019, stock short name: Allmed Medical; stock code: 002950.SZ. The company's domestic core business focuses on professional medical and consumer medical fields, with professional medical products covering three parts: medical wound care, medical surgical consumables, and medical infection protection, making it a trusted partner of clinical professional customers. Consumer medical products cover home wound care, personal cleaning care, home health care three parts, distribution covers ten thousand chain pharmacies and online e-commerce channels, and strive to create multi-level, multi-scenario products and services, to provide one-stop solutions for end-users. The company has six core production bases, including an advanced manufacturing base for medical devices, a fully automated surgical towel production base, a production base for medical non-woven and hygiene care products, a production base for functional dressings, a production base for overseas textile and protective products, and a production base and sales centre in Europe, as well as 680,000 square metres of modern factory buildings, supported by 100 industry-leading automated and intelligent production lines. The company insists on pioneering innovation and leads the industry in technological progress, and has obtained more than nearly 500 national patents and more than 20 software copyrights. The company has long been focusing on the R&D, production and sales of disposable medical consumables and sanitary products, focusing on the in-depth integration of the medical dressing industry chain, and has formed a complete industry chain from primary raw materials to deep processing, packaging, sterilisation, testing and so on, which runs through all the production links, and it is the only one company in the world to realise the integrated, large-scale and intelligent production of the whole industry chain manufacturing enterprise in the fields of medical dressings, infectious protection products and medical non-woven products. It is the only one in the world to achieve integrated, large-scale and intelligent production of medical dressings and medical non-woven products. The company practices the vision of ‘the leader of healthy life, the creator of quality life’. We will continue to provide high-quality products and services for domestic and foreign users, and guard life at every moment!

Announcements

0 total
No announcements match your search.